Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 75 Records) |
| Query Trace: Neoplasms and CCNE1[original query] |
|---|
| Comprehensive Study of Human FBXW7 Deleterious nsSNP's Functional Inference and Susceptibility to Gynaecological Cancer. Applied biochemistry and biotechnology 2021 11 194 (1): 407-433. Vasuki K Archana, Christy H Jem |
| Molecular Landscape and Prognostic Biomarker Analysis of Advanced Pancreatic Cancer and Predictors of Treatment Efficacy of AG Chemotherapy. Frontiers in oncology 2022 12 844527. Du Juan, Qiu Xin, Lu Changchang, Zhu Yahui, Kong Weiwei, Xu Mian, Zhang Xin, Tang Min, Chen Jun, Li Qi, Li Aimei, He Jian, Gu Qing, Wang Lei, Qiu Yudong, Liu Baor |
| Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer. The Prostate 2022 6 82 (13): 1264-1272. Bray Alexander W, Duan Rong, Malalur Pannaga, Drusbosky Leylah M, Gourdin Theodore S, Hill Elizabeth G, Lilly Michael |
| Diet quality, common genetic polymorphisms, and bladder cancer risk in a New England population-based study. European journal of nutrition 2022 Jun . Leeming Reno C, Koutros Stella, Karagas Margaret R, Baris Dalsu, Schwenn Molly, Johnson Alison, Zens Michael S, Schned Alan R, Rothman Nathaniel, Silverman Debra T, Passarelli Michael |
| High cyclin E1 protein, but not gene amplification, is prognostic for basal-like breast cancer. The journal of pathology. Clinical research 2022 4 8 (4): 355-370. Aziz Diar, Lee Christine, Chin Venessa, Fernandez Kristine J, Phan Zoe, , , Waring Paul, Caldon C Elizabe |
| Role of Genetic Variations in CDK2, CCNE1 and p27 in Prostate Cancer. Cancer genomics & proteomics 2022 4 19 (3): 362-371. Híveš Márk, Jure?eková Jana, Kliment Ján, Grendár Marián, Kaplán Peter, Dušenka Róbert, Evin Daniel, Vil?ková Marta, Hole?ková Klaudia Híveš, Sivo?ová Monika Kme?o |
| Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer. Scientific reports 2022 02 12 (1): 2167. Sitthideatphaiboon Piyada, Teerapakpinyo Chinachote, Korphaisarn Krittiya, Leelayuwatanakul Nophol, Pornpatrananrak Nopporn, Poungvarin Naravat, Chantranuwat Poonchavist, Shuangshoti Shanop, Aporntewan Chatchawit, Chintanapakdee Wariya, Sriuranpong Virote, Vinayanuwattikun Chani |
| Characterization of genomic alterations and neoantigens and analysis of immune infiltration identified therapeutic and prognostic biomarkers in adenocarcinoma at the gastroesophageal junction. Frontiers in oncology 2022 11 12 941868. Lao Yueqiong, Wang Yuqian, Yang Jie, Liu Tianyuan, Ma Yuling, Luo Yingying, Sun Yanxia, Li Kai, Zhao Xuan, Niu Xiangjie, Xi Yiyi, Zhong |
| Chromosomally Unstable Gastric Cancers Overexpressing Claudin-6 Disclose Cross-Talk between HNF1A and HNF4A, and Upregulated Cholesterol Metabolism. International journal of molecular sciences 2022 11 23 (22): . Dwivedi Sanyog, Hernández-Montes Georgina, Montaño Luis Felipe, Rendón-Huerta Erika Patric |
| Molecular analysis of endometrial serous carcinoma reveals distinct clinicopathologic and genomic subgroups. Gynecologic oncology 2022 1 164 (3): 558-565. Lin Douglas I, Fine Alexander, Danziger Natalie A, Huang Richard S P, Mata Douglas A, Decker Brennan, Killian Jonathan K, Ramkissoon Shakti H, Lechpammer Mirna, Janovitz Tyler, Ross Jeffrey S, Sokol Ethan S, Elvin Julia |
| Unique Genomic Alterations and Microbial Profiles Identified in Gastric Cancer Patients of African, European, and Asian Ancestry: A Novel Path for Precision Oncology. Annals of surgery 2023 7 . Miseker Abate, Henry Walch, Kanika Arora, Chad M Vanderbilt, Teng Fei, Harrison Drebin, Shoji Shimada, Anna Maio, Yelena Kemel, Zsofia K Stadler, Joseph Schmeltz, Smita Sihag, Geoffrey Y Ku, Ping Gu, Laura Tang, Santosha Vardhana, Michael F Berger, Murray F Brennan, Nikolaus D Schultz, Vivian E Stro |
| A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors. Targeted oncology 2023 6 . Todd M Bauer, Kathleen N Moore, Janet S Rader, Fiona Simpkins, Alain C Mita, J Thaddeus Beck, Lowell Hart, Quincy Chu, Amit Oza, Anna V Tinker, Esteban Rodrigo Imedio, Sanjeev Kumar, Ganesh Mugundu, Suzanne Jenkins, Juliann Chmielecki, Suzanne Jones, David Spigel, Siqing |
| Genomic characterization between HER2-positive and negative gastric cancer patients in a prospective trial. Cancer medicine 2023 6 . Qingjiang Hu, Eiji Oki, Teppei Yamada, Tomomi Kashiwada, Hideto Sonoda, Masato Kataoka, Hirofumi Kawanaka, Yasushi Tsuji, Akitaka Makiyama, Yuichiro Nakashima, Mitsuhiko Ota, Yasue Kimura, Tomoharu Yoshizu |
| Prostate cancer genetic alterations in Hispanic men. The Prostate 2023 6 . Camilo Arenas-Gallo, Stephen Rhodes, Jorge A Garcia, Ilon Weinstein, Megan Prunty, Patrick Lewicki, Aaron Brant, Spyridon P Basourakos, Christopher E Barbieri, Noa Lifschutz, Fredrick R Schumacher, Jonathan E Sho |
| Comprehensive genomic and immunohistochemical profiles and outcomes of immunotherapy in patients with recurrent or advanced cervical cancer. Frontiers in oncology 2023 5 13 1156973. Yoo-Na Kim, Kyunglim Lee, Eunhyang Park, Junsik Park, Yong Jae Lee, Eun Ji Nam, Sang Wun Kim, Sunghoon Kim, Young Tae Kim, Jung-Yun L |
| Genomic alterations of cerebrospinal fluid cell-free DNA in leptomeningeal metastases of gastric cancer. Journal of translational medicine 2023 5 21 (1): 296. Xin Chen, Kaixuan Bai, Yu Zhang, Yang Xu, Yinghao Huo, Sha Wang, Yueli Zou, Xuejiao Qi, Rongyun Guo, Qiuxiang Ou, Dengxiang Liu, Shaohua Yin, Shubo Chen, Hui |
| The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD-L1 expression. Cancer medicine 2023 12 . Xiaoqian Jing, Zhiping Luo, Jiayan Wu, Feng Ye, Jianfang Li, Zijia Song, Yaqi Zhang, Minmin Shi, Huaibo Sun, Yi Fang, Yimei Jiang, Xiaopin |
| Serial circulating-tumor DNA analysis with a tumor naïve next-generation sequencing panel detects minimal residual disease and predicts outcome in ovarian cancer. Cancer research 2023 12 . Jinho Heo, Yoo-Na Kim, Saeam Shin, Kyunglim Lee, Ji-Hyun Lee, Yong Jae Lee, Zisun Choi, Jihyang Park, Seungki Min, Sang Wun Kim, Jong Rak Choi, Sunghoon Kim, Seung-Tae Lee, Jung-Yun L |
| Implementation of Comprehensive Genomic Profiling in Ovarian Cancer Patients: A Retrospective Analysis. Cancers 2023 1 15 (1): . Peleg Hasson Shira, Hershkovitz Dov, Adar Lyri, Brezis Miriam, Shachar Eliya, Aks Rona, Galmor Lee, Raviv Yuval, Ben Neriah Shira, Merimsky Ofer, Sabo Edmond, Wolf Ido, Safra Tam |
| Integrative Bioinformatics Analysis: Unraveling Variant Signatures and Single-Nucleotide Polymorphism Markers Associated with 5-FU-Based Chemotherapy Resistance in Colorectal Cancer Patients. Journal of gastrointestinal cancer 2024 9 . Masomeh Askari, Ebrahim Mirzaei, Leila Navapour, Mina Karimpour, Leili Rejali, Somayeh Sarirchi, Ehsan Nazemalhosseini-Mojarad, Stefania Nobili, Claudia Cava, Amir Sadeghi, Nayeralsadat Fate |
| Molecular landscape and clinical implication of CCNE1-amplified esophagogastric cancer. Cancer research communications 2024 5 . Naryan Rustgi, Sharon Wu, Timothy Samec, Phillip Walker, Joanne Xiu, Emil Lou, Sanjay Goel, Anwaar Saeed, Ryan H M |
| Different genetic profiles contribute to worse overall survival in patients with leptomeningeal metastases of non-small-cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 5 . Xusheng Tang, Xiaojuan Hu, Lin Yuan, Hainan Yang, Yunfen Luo, Da Liu, Qingjun Hu, Changguo Shan, Tao Lin, Linbo Cai, Zhaoming Zhou, Xin Jin, Ming Lei, Weiping Ho |
| Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric Cancer. JCO precision oncology 2024 5 8 e2300681. Kyoko Yamaguchi, Mamoru Ito, Taichi Isobe, Sakuya Koreishi, Ryosuke Taguchi, Koki Uehara, Shohei Ueno, Takashi Imajima, Takafumi Kitazono, Kenji Tsuchihashi, Hirofumi Ohmura, Tomoyasu Yoshihiro, Kenro Tanoue, Satoshi Nishiyori, Eiji Iwama, Takahiro Maeda, Koichi Akashi, Eishi Ba |
| Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a multicenter, retrospective cohort study. BMC medicine 2024 12 22 (1): 585. Xue Zhang, Xin Dai, Aina Liu, Meili Sun, Lei Cong, Jing Liang, Zimin Liu, Zhen Li, Jinling Zhang, Jing Lv, Fangli Cao, Linli Qu, Haiyan Liu, Lu Yue, Yi Zhai, Fujun Yang, Jiahui Chu, Shuang Wang, Qian Xu, Jianyuan Zhou, Shulun Nie, Miao Huang, Ruitao Xu, Qiushi Wang, Xinyu Song, Di Zhang, Zhaodi Nan, Song Li, Lian L |
| Patterns of genomic instability in?>?2000 patients with ovarian cancer across six clinical trials evaluating olaparib. Genome medicine 2024 12 16 (1): 145. Alan Barnicle, Isabelle Ray-Coquard, Etienne Rouleau, Karen Cadoo, Fiona Simpkins, Carol Aghajanian, Alexandra Leary, Andrés Poveda, Stephanie Lheureux, Eric Pujade-Lauraine, Benoit You, Jonathan Ledermann, Ursula Matulonis, Charlie Gourley, Kirsten M Timms, Zhongwu Lai, Darren R Hodgson, Cathy E Elks, Simon Dearden, Coumaran Egile, Pierre Lao-Sirieix, Elizabeth A Harrington, Jessica S Bro |
| Age-related genomic alterations and chemotherapy sensitivity in osteosarcoma: insights from cancer genome profiling analyses. International journal of clinical oncology 2024 12 . Hidetatsu Outani, Masachika Ikegami, Yoshinori Imura, Sho Nakai, Haruna Takami, Yuki Kotani, Akitomo Inoue, Seiji Oka |
| Pan-cancer analysis identifies the oncogenic role of CCNE1 in human cancers. Aging 2024 11 null . Yujie Ouyang, Ziyi Wu, Dilihumaer Aili, Chunhua Yang, Hui Zhang, Tong |
| Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases. Frontiers in endocrinology 2024 10 15 1364021. Ariel R Choi, Ralph B D'Agostino, Michael K Farris, Mohammed Abdulhaleem, John C Hunting, Yuezhu Wang, Margaret R Smith, Jimmy Ruiz, Thomas W Lycan, W Jeffrey Petty, Christina K Cramer, Stephen B Tatter, Adrian W Laxton, Jaclyn J White, Wencheng Li, Jing Su, Christopher Whitlow, Fei Xing, Michael D Ch |
| Race- associated molecular differences in uterine serous carcinoma. Frontiers in oncology 2024 10 14 1445128. Olivia D Lara, Hannah Karpel, Steven Friedman, Kari E Hacker, Bhavana Pothu |
| Genomic landscape of circulating tumor DNA and real-world outcomes in advanced endometrial cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 10 . Pamela Soberanis Pina, Keelia Clemens, Adrian Bubie, Brooke Grant, Ginger Haynes, Nicole Zhang, Leylah Drusbosky, Stephanie Lheure |
- Page last reviewed:Feb 1, 2024
- Content source: